DILH
WX

Dai-ichi Life Holdings’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Dai-ichi Life Holdings’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-7,900
Closed -$291K – 670
2014
Q1 		$291K Sell
7,900
-1,100
-12% -$40.4K 0.01% 508
2013
Q4 		$345K Buy
+9,000
New +$284K 0.01% 481

Other funds holding WX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dai-ichi Life Holdings's WX Position: Q2 2014 in Review

Dai-ichi Life Holdings sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2014, closing a stake of 7,900 shares — an estimated $291K sold.

Dai-ichi Life Holdings first reported a position in WX in Q4 2013 and held it in 2 quarters. The position peaked at $345K in Q4 2013. 154 funds tracked by Wall St. Rank hold WX as of Q2 2014.

  • Dai-ichi Life Holdings reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2014 after selling out during the quarter.
  • Dai-ichi Life Holdings sold 7,900 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2014, an estimated $291K.
  • Dai-ichi Life Holdings first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2013 and held it in 2 quarters.
  • Dai-ichi Life Holdings's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $345K in Q4 2013.
  • 154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2014.

Based on Dai-ichi Life Holdings's 13F filing for Q2 2014, filed 14 Aug 2014.